China now India’s top coir export destination

India exported 537,040 tonnes of coir and coir products, valued at Rs 1,476 crore (US$ 250.96 million) during FY14, registering a growth of 32 per cent. China has replaced the US as the biggest importer of coir-based products from India, according to Mr G Balachandran, Chairman, Coir Board, India.

India to support irrigation project in Rwanda

Rwanda is taking up an irrigation project with US$ 120 million assistance from the Government of India. India has already routed in about US$ 500 million of foreign direct investments (FDI) in Rwanda.

NRI deposits rise by US$ 33.3 billion in FY14

Non-resident Indians (NRI) deposits swelled by US$ 33.28 billion in 2013-14 at US$ 104.10 billion as against US$ 70.21 billion in the previous year, according to Reserve Bank of India (RBI).

IT infra market will touch US$ 1.9 billion this year

The Indian IT infrastructure market — comprising server, storage and networking equipment — is expected to touch US$ 1.9 billion in 2014 registering a growth of four per cent, according to Gartner.

IIM-A ranks fourth in Economist good value MBAs

The Economist has ranked India’s premier business school, Indian Institute of Management Ahmedabad (IIM-A), fourth among 20 leading schools globally in terms of return on investment (RoI) for its students.

FII holding in India Inc hit a record high of 25% in Q4

The stakes held by foreign institutional investors (FII) in Indian companies touched a record high in the fourth quarter (Q4) of FY14. The estimated value of FII holdings in India stands at US$ 279 billion.

Indian IT companies to tap big business in Europe

With European companies looking at making outsourcing mainstream, Indian software companies are tapping into a rich new vein of opportunity. Indian technology companies are firming up hiring plans and are looking for acquisitions in the continent.

US Company Cancer Genetics Inc buys India's genomics firm BioServe

Cancer Genetics Inc (CGI) has acquired Hyderabad-based genomics services provider BioServe India for US$ 1.9 million. "With BioServe, we will become better positioned to increase our global presence in personalised cancer care," said Mr Panna Sharma, CEO, CGI.

Cabinet clears KKR's US$ 400 million pharma FDI proposal

The Union Cabinet of India has cleared foreign investment proposal worth US$ 400 million by KKR to acquire stakes in two pharmaceutical companies Gland Pharma and Gland Celsus Bio Chemicals.

Cipla invests US$ 1.5 million in Chase Pharma

Cipla has invested US$ 1.5 million in the US-based Chase Pharmaceuticals Corporation Inc through its subsidiary, Cipla (EU) Ltd. Chase, which has a patented approach to improve the efficacy, safety and tolerability of existing Alzheimer’s medications, is now focused on developing new approaches to treat the disease.